Passage Bio, Inc. (PASG)
NASDAQ·Healthcare·Biotechnology
$4.47
-2.30%
Mkt Cap $27.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
Implied Upside
+124.0%
Consensus $10.00 vs current $4.47
NASDAQ·Healthcare·Biotechnology
$4.47
-2.30%
Mkt Cap $27.94M
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
+124.0%
Consensus $10.00 vs current $4.47